India Financial News

Subscribe to enjoy similar stories.Sun Pharmaceutical Industries Ltd’s acquisition of Organon might yet avoid the pitfalls that its rivals, Lupin Ltd and Biocon Ltd, have faced in the past. Billed as among the largest deals in the Indian pharma space, the Sun-Organon deal is in a better place than the Lupin-Gavis and the Biocon-Viatris deals.When Lupin completed the acquisition of US-based Gavis Pharmaceuticals in March 2016, the former’s stock went downhill.

Subscribe to enjoy similar stories.The India-New Zealand free trade agreement (FTA) signed on Monday is the latest in a series of bilateral pacts India has struck. Once operationalized, it will allow India zero-duty access for all goods along with easier mobility for professionals to work in New Zealand, which has also committed to invest $20 billion in India over many years.

Subscribe to enjoy similar stories.Mumbai: India’s second-biggest overseas acquisition was stitched together over three months of near-daily negotiations between the bidder, the seller and their bankers, said a banker aware of the details behind the transaction.Mumbai-based Sun Pharmaceutical Industries Ltd on Monday said in an exchange filing it will acquire US-headquartered Organon & Co for about $11.75 billion. This is the largest overseas deal by an Indian company since Tata Steel acquired UK-based Corus Group for $12 billion in 2007.The deal was always pitched at around $12 billion from both sides, with negotiations neither exceeding nor materially falling from that level, the person cited above said on the condition of anonymity.“The deal was out in the market sometime late 2025, and Sun was very interested because it gave them access to more than 100 countries across the world and also complemented the product suite,” said the banker.

Subscribe to enjoy similar stories.India's weakest monsoon forecast in 26 years hasn't rattled Dalal Street much, raising the risk that investors are underpricing pockets of stress.The India Meteorological Department’s (IMD) first estimate pegs 2026 rainfall at 92% of the long-period average (LPA), flagging chances of below-normal precipitation. Amid persistent foreign investor outflows, elevated crude prices and patchy earnings, monsoon risks are being seen as incremental.However, experts caution that a weak monsoon could choke farm cash flows, dampen rural credit demand, and sour asset quality before broader consumption trends buckle.Non-banking financial companies (NBFCs) with exposure to vehicle loans and micro, small, and medium enterprise (MSME) financing in rural markets are most closely aligned with the monsoon cycle.Unlike fast-moving consumer goods (FMCG), consumer durables, and autos—which can cushion rural weakness through premiumization and urban demand—these lenders' books are directly tied to farm incomes.The Centre for Monitoring Indian Economy (CMIE) expects rabi crop income to grow just 0.8% year-on-year in FY26 due to low food inflation, down from almost 11% last year and well below the above-8% annual trend seen since FY16.

Subscribe to enjoy similar stories.NewSpace India Ltd (NSIL), the commercial arm of Indian Space Research Organisation (Isro), has raised satellite bandwidth prices by 20%, effective 1 April, marking its first revision in a decade and signalling a reset in how scarce orbital capacity is priced amid shifting demand.The increase, communicated to customers in a letter dated 18 September, reviewed by Mint, will affect broadcasters, direct-to-home (DTH) platforms and companies leasing capacity for TV distribution, connectivity for ATMs and remote areas, maritime and defence projects, and enterprise communications.The move comes as demand dynamics shift, with traditional DTH usage weakening even as aviation, maritime and defence applications seek capacity, prompting a long-delayed pricing correction.“NSIL management has decided to revise the pricing of Ku-band capacity in three satellites—Gsat-31, Gsat-10 and Gsat-16. This is the first price revision of government satellites after 2016.

Subscribe to enjoy similar stories.In a shift from the ‘growth at any cost’ era, IT services industry leaders like Infosys Ltd, HCL Technologies Ltd, and Tech Mahindra Ltd are increasingly avoiding low-margin contracts, preferring to sacrifice top-line revenue to protect their bottom lines from the impact of artificial intelligence (AI).The change comes as generative AI begins to affect the traditional outsourcing model. By automating tasks that previously required thousands of engineers, AI is compressing deal values and forcing firms to choose between hyper-competitive, low-yield work and more lucrative, automated services.The impact of this selectivity is already showing up in the books.

Subscribe to enjoy similar stories.A decade has passed since India began rebuilding inclusive and progressive infrastructure for women, with the gender budget hitting ₹5 trillion in 2026-27. This represents around 9% of the Centre’s total expenditure.While the push for women’s inclusion through higher expenditure is visible, and millions of women are part of several schemes encompassing self-help groups, small businesses, and employment, among others, several gaps remain that raise questions about whether these benefits are just on paper.Data shows that over 50 million women beneficiaries are under the Pradhan Mantri Mudra Yojana (PMMY), and over 100 million under self-help groups, but very few are registered businesses—the share of formally registered enterprises run by women was just 20.5% in 2023-24, marginally up from 17.5% in 2021-22.While the gender budget has grown in size, the internal architecture suggests a shifting focus towards livelihood rather than women-led industrialization.

Subscribe to enjoy similar stories.Sun Pharmaceutical Industries Ltd on Monday announced the $11.75 billion acquisition of Organon & Co., in a seemingly aggressive push into the US market that has long decided the global fortunes of Indian drugmakers. However, the biggest buyout by an Indian company in nearly 20 years also signals that the US generics market's decades-long allure is beginning to fade for Indian drugmakers, which are now eyeing newer markets such as China, South Korea, and Spain with branded generics.Announced early on Monday, the Organon acquisition ranks as the second-largest acquisition by an Indian company, behind Tata Steel's 2007 deal to buy British steel maker Corus Group for $12 billion.For years, Indian pharma rode a powerful wave in the US, as expiring patents of blockbuster small-molecule drugs opened a gold mine for low-cost generic drug makers in the world's largest drug market.

Subscribe to enjoy similar stories.For those who have faced a shortage of small-value notes and coins in their wallets, the next three months could bring a change.India’s largest lender, State Bank of India (SBI), is looking to install dozens of cash and coin dispensers by the end of June, as it leads an initiative by the government and the Reserve Bank of India (RBI) to ease access to low-denomination paper money and coins.The state-owned lender plans to install 60 such machines in markets and other high-traffic areas where demand for change is high, according to four people familiar with the development and a document seen by Mint.The rollout will cover branches with currency chests in cities such as Bengaluru, Pune, Amravati, Chandigarh, Vellore, and Shimla, among others. The idea is to cover 13-14 states, the person said.“If the bank sees usage pickup at these machines, it will gradually increase the number.

Subscribe to enjoy similar stories.Stock market recap: The market rally on Monday, 27 April, was driven by sectoral recoveries and easing geopolitical tensions. Sun Pharmaceutical Industries surged more than 7%, leading Nifty gainers after announcing an $11.75 billion acquisition of Organon.

Subscribe to enjoy similar stories.Although initial resistance levels were briefly broken on Monday, the market continues to show hesitation, preventing a clear breakout or a stronger trend. Nevertheless, the fact that bullish momentum has persisted despite periodic volatility has increased overall market confidence.Buy above ₹890, stop ₹835, target ₹990 (multiday)Buy above ₹465, stop ₹435, target ₹515 (multiday)Buy above ₹520, stop ₹490, target ₹580 (multiday)Indian equities rebounded on 27 April, snapping a three-day losing streak as easing geopolitical concerns lifted sentiment.

Subscribe to enjoy similar stories.A nationwide shortage of Diet Coke is creating an opportunity for India’s direct-to-consumer zero-sugar beverage brands to win new customers as supply disruptions leave multinational soda makers short on shelves this summer.With demand for low-calorie drinks rising during the peak summer months of April and May, newer beverage companies are using the disruption to attract consumers who may not find their usual diet cola, betting that temporary shortages could translate into repeat purchases, industry executives told Mint.For many of these startups, including Paper Boat Zero, Chinni Kum, Zyro, and Jimmy's, the disruption has been less severe because a large part of their portfolio is sold in PET bottles rather than aluminium cans.Ankur Bhatia, founder of Jimmy’s, said the company’s bottle-based packaging has given it a ‘tactical edge’ because shortages in aluminium cans have worsened as beer and soft drink makers compete for the same production capacity. “The can-making lines are the same.

Subscribe to enjoy similar stories.MUMBAI: Alvarez & Marsal (A&M) plans to scale up its corporate finance team in India and expand into new sectors, as the New York-based consulting firm positions itself to capture a rise in dealmaking and sustained capital inflows into the country, senior executives said.The expansion comes amid a shift in global investor strategy towards long-term capital deployment in India, driven by strong underlying fundamentals, high-growth prospects and elevated public market valuations that are pushing deal activity, including cross-border transactions.“We are building a highly sector-specialized corporate finance team, that integrates seamlessly with the firm’s other offerings,” said Mohit Khullar, managing director and head of corporate finance at Alvarez & Marsal India.The firm’s corporate finance practice currently spans consumer, industrials, healthcare and pharma, with the recent addition of Nitin Lath as managing director for the sector.“We will specialize within pharma, with a strong focus on Indian branded formulations, niche generics and speciality pharma, as well as CDMOs (contract development and manufacturing organization) and APIs (active pharmaceutical ingredients),” Lath said. “The pharma industry is undergoing a period of transformation, with several players re evaluating their business models and actively pursuing large M&A opportunities, including cross border transactions across the US and Europe.”Khullar said the firm will also expand into additional sectors such as financial services and technology in the coming months.

Subscribe to enjoy similar stories.In 2025, renewables surpassed coal in the global power mix for the first time in over a century, according to a new report by energy think tank Ember. India and China played a pivotal role in this transformation, with electricity generated from fossil fuels falling in both countries.However, coal still accounts for more than 70% of India’s electricity.

Subscribe to enjoy similar stories.One MobiKwik Systems Ltd expects to see margins improve after the Reserve Bank of India approved its application for a non-banking financial company (NBFC) licence, the company’s top executive told Mint.This marks a key regulatory milestone for the listed fintech as it looks to deepen its lending business. The licence will sit under wholly owned subsidiary MobiKwik Financial Services Pvt Ltd.“We have got this NBFC license to make our business more efficient and improve on margins,” said Bipin Preet Singh, chief executive officer of MobiKwik.

Subscribe to enjoy similar stories.JSW MG Motor India Pvt. Ltd, the joint venture between China’s SAIC Motor Corp.

Subscribe to enjoy similar stories.Mumbai: From technology to automobiles to pharmaceuticals, Indian companies are scaling up their global ambitions like never before.They are using large acquisitions overseas to quickly scale, deliver higher value products and compete on the global stage. The latest one—Sun Pharmaceutical Industries Ltd’s $11.75 billion acquisition of US-based specialty drugmaker Organon & Co, second only to the Tata Steel's $12-billion purchase of Corus Group nearly two decades ago, caps a year of such bold bets.Whether it is Coforge Ltd’s $2.39 billion buyout of California-based Encora, Tata Motors Ltd’s $4.5 billion bet on Italy’s Iveco, or Bajaj Auto Ltd’s $906 million acquisition of its long-time Austrian partner KTM, Indian companies are spending top dollar on acquiring companies overseas, which give them access to technology and newer markets.Coforge is an IT services provider that caters to legacy companies.

Subscribe to enjoy similar stories.BENGALURU: India’s café chains are moving beyond traditional coffee-led formats and experimenting with dessert-focused concepts, hybrid cafés and experience-led stores to drive higher engagement and spending.Last week, Westbridge Capital-backed Third Wave Coffee launched “Third Rush” at four of its outlets in Bengaluru, branding and positioning desserts as a standalone experience aimed at enhancing late-evening socializing.“We see desserts evolving into a strategic lever that supports higher engagement and ticket size,” Rajat Luthra, chief executive officer (CEO) of Third Wave Coffee, told Mint.Barista Coffee recently started diner-style outlets that offer a more expansive set of meal items like burgers and pastas and hybrid cafés that serve coffee and food items, while Tata Starbucks already has desserts as part of its food menu and is expanding a mix of neighbourhood stores and more immersive Reserve formats.These formats are becoming more specialized. Dessert-led menus and artisanal bakery tie-ups are helping chains move beyond beverages into full-stack consumption.

Subscribe to enjoy similar stories.The impossible trinity, or trilemma, holds that a country cannot simultaneously maintain a fixed exchange rate, free capital movement, and an independent monetary policy; policymakers must prioritise two at the expense of the third.A strikingly similar trilemma sits at the heart of health insurance: the insurer’s duty to settle claims sustainably, the hospital’s duty to deliver effective, patient-centred care while earning a fair return, and the customer’s demand for affordability. Like the economic trilemma, this cannot be resolved by decree.

Subscribe to enjoy similar stories.For years, the global AI race focused on frontier models, faster chips and massive capital. The US still leads this phase, with its hyperscalers ready to roll out massive expansions of data centre capacity as soon as labour, chip and power availability catch up. China, however, is shifting its strategy.

Subscribe to enjoy similar stories.The Bureau of Indian Standards (BIS) has notified new design requirements for offshore wind turbines, blades, and tower and foundation structures, in line with International Electrotechnical Commission (IEC) standards, according to two government officials aware of the development.The new standards aim to establish clear benchmarks for the design, testing and installation of key components of wind energy systems, particularly in offshore conditions where operational risks are higher.“These norms would ensure structural safety, improve quality control and enhance the reliability of wind installations,” said one of the two officials.“By aligning with IEC-based standards, the move ensures global compatibility and is expected to facilitate greater participation from international players, while supporting technology transfer and investment in the sector,” the official added.This comes as India pushes to scale up its offshore wind sector, which has an estimated potential of 70 gigawatts (GW), enough to power nearly 70 million households. The country aims to auction about 37GW of offshore capacity by 2029-30.Offshore wind projects cost around ₹15- ₹20 crore per megawatt (MW), significantly higher than ₹7- ₹8 crore per MW for onshore projects, due to the need for seabed infrastructure and transmission systems.